
Scott Long
Examiner (ID: 10754, Phone: (571)272-9048 , Office: P/1633 )
| Most Active Art Unit | 1633 |
| Art Unit(s) | 1633 |
| Total Applications | 882 |
| Issued Applications | 557 |
| Pending Applications | 29 |
| Abandoned Applications | 301 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4949421
[patent_doc_number] => 20080305547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-11
[patent_title] => 'Method for enhanced functional expression of cell receptors'
[patent_app_type] => utility
[patent_app_number] => 11/810553
[patent_app_country] => US
[patent_app_date] => 2007-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2610
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0305/20080305547.pdf
[firstpage_image] =>[orig_patent_app_number] => 11810553
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/810553 | Method for enhanced functional expression of cell receptors | Jun 5, 2007 | Abandoned |
Array
(
[id] => 5479532
[patent_doc_number] => 20090202489
[patent_country] => US
[patent_kind] => A2
[patent_issue_date] => 2009-08-13
[patent_title] => 'ADENOVIRUSES MUTATED IN THE VA GENES FOR CANCER TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 11/809191
[patent_app_country] => US
[patent_app_date] => 2007-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6191
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A2/0202/20090202489.pdf
[firstpage_image] =>[orig_patent_app_number] => 11809191
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/809191 | Adenoviruses mutated in the VA genes for cancer treatment | May 30, 2007 | Abandoned |
Array
(
[id] => 5479532
[patent_doc_number] => 20090202489
[patent_country] => US
[patent_kind] => A2
[patent_issue_date] => 2009-08-13
[patent_title] => 'ADENOVIRUSES MUTATED IN THE VA GENES FOR CANCER TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 11/809191
[patent_app_country] => US
[patent_app_date] => 2007-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6191
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A2/0202/20090202489.pdf
[firstpage_image] =>[orig_patent_app_number] => 11809191
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/809191 | ADENOVIRUSES MUTATED IN THE VA GENES FOR CANCER TREATMENT | May 30, 2007 | Abandoned |
Array
(
[id] => 4797065
[patent_doc_number] => 20080008651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-10
[patent_title] => 'Screening Methods and Transgenic Animals for the Treatment of Beta-Globin Related Disease and Conditions'
[patent_app_type] => utility
[patent_app_number] => 11/754197
[patent_app_country] => US
[patent_app_date] => 2007-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 21969
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20080008651.pdf
[firstpage_image] =>[orig_patent_app_number] => 11754197
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/754197 | Screening Methods and Transgenic Animals for the Treatment of Beta-Globin Related Disease and Conditions | May 24, 2007 | Abandoned |
Array
(
[id] => 6477085
[patent_doc_number] => 20100285031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'Hox Compositions and Methods'
[patent_app_type] => utility
[patent_app_number] => 12/227551
[patent_app_country] => US
[patent_app_date] => 2007-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 50149
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 35
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0285/20100285031.pdf
[firstpage_image] =>[orig_patent_app_number] => 12227551
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/227551 | Hox Compositions and Methods | May 20, 2007 | Abandoned |
Array
(
[id] => 5270958
[patent_doc_number] => 20090074734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'MICROBIAL INTESTINAL DELIVERY OF OBESITY RELATED PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 12/299093
[patent_app_country] => US
[patent_app_date] => 2007-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8523
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20090074734.pdf
[firstpage_image] =>[orig_patent_app_number] => 12299093
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/299093 | MICROBIAL INTESTINAL DELIVERY OF OBESITY RELATED PEPTIDES | May 1, 2007 | Abandoned |
Array
(
[id] => 4965270
[patent_doc_number] => 20080108090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-08
[patent_title] => 'Methods of identifying small molecules for renewal, survival and migration of cardiac progenitors'
[patent_app_type] => utility
[patent_app_number] => 11/799839
[patent_app_country] => US
[patent_app_date] => 2007-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 14940
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20080108090.pdf
[firstpage_image] =>[orig_patent_app_number] => 11799839
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/799839 | Methods of identifying small molecules for renewal, survival and migration of cardiac progenitors | May 1, 2007 | Abandoned |
Array
(
[id] => 5230390
[patent_doc_number] => 20070292497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-20
[patent_title] => 'Method for treating micrometastatic tumors'
[patent_app_type] => utility
[patent_app_number] => 11/799652
[patent_app_country] => US
[patent_app_date] => 2007-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6003
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20070292497.pdf
[firstpage_image] =>[orig_patent_app_number] => 11799652
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/799652 | Method for treating micrometastatic tumors | May 1, 2007 | Abandoned |
Array
(
[id] => 4977219
[patent_doc_number] => 20070218451
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-20
[patent_title] => 'PEROXISOME-PROLIFERATOR ACTIVATED RECEPTOR-ALPHA AGONISTS FOR ORGAN PRESERVATION'
[patent_app_type] => utility
[patent_app_number] => 11/687419
[patent_app_country] => US
[patent_app_date] => 2007-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5489
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0218/20070218451.pdf
[firstpage_image] =>[orig_patent_app_number] => 11687419
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/687419 | Peroxisome-proliferator activated receptor-alpha agonists for organ preservation | Mar 15, 2007 | Issued |
Array
(
[id] => 5010850
[patent_doc_number] => 20070281329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-06
[patent_title] => 'Characterization of individual polymer molecules based on monomer-interface interactions'
[patent_app_type] => utility
[patent_app_number] => 11/717319
[patent_app_country] => US
[patent_app_date] => 2007-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 16288
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20070281329.pdf
[firstpage_image] =>[orig_patent_app_number] => 11717319
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/717319 | Characterization of individual polymer molecules based on monomer-interface interactions | Mar 12, 2007 | Abandoned |
Array
(
[id] => 5521437
[patent_doc_number] => 20090029418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-29
[patent_title] => 'METHOD FOR CLONING AND EXPRESSION OF STUI RESTRICTION ENDONUCLEASE AND STUI METHYLASE IN E. COLI'
[patent_app_type] => utility
[patent_app_number] => 12/279359
[patent_app_country] => US
[patent_app_date] => 2007-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6308
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20090029418.pdf
[firstpage_image] =>[orig_patent_app_number] => 12279359
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/279359 | Method for cloning and expression of StuI restriction endonuclease and StuI methylase in E. coli | Feb 26, 2007 | Issued |
Array
(
[id] => 4872710
[patent_doc_number] => 20080199444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-21
[patent_title] => 'Composition and method for reducing feces toxins and treating digestive disorders'
[patent_app_type] => utility
[patent_app_number] => 11/707607
[patent_app_country] => US
[patent_app_date] => 2007-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4361
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20080199444.pdf
[firstpage_image] =>[orig_patent_app_number] => 11707607
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/707607 | Composition and method for reducing feces toxins and treating digestive disorders | Feb 15, 2007 | Issued |
Array
(
[id] => 4955749
[patent_doc_number] => 20080188773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-07
[patent_title] => 'Method for the identification, diagnosis and treatment of somatic dysfunctions'
[patent_app_type] => utility
[patent_app_number] => 11/702772
[patent_app_country] => US
[patent_app_date] => 2007-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3411
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0188/20080188773.pdf
[firstpage_image] =>[orig_patent_app_number] => 11702772
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/702772 | Method for the identification, diagnosis and treatment of somatic dysfunctions | Feb 5, 2007 | Issued |
Array
(
[id] => 5071782
[patent_doc_number] => 20070192884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'TAT-038 and methods of assessing and treating cancer'
[patent_app_type] => utility
[patent_app_number] => 11/698245
[patent_app_country] => US
[patent_app_date] => 2007-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 66947
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20070192884.pdf
[firstpage_image] =>[orig_patent_app_number] => 11698245
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/698245 | TAT-038 and methods of assessing and treating cancer | Jan 24, 2007 | Abandoned |
Array
(
[id] => 8005245
[patent_doc_number] => 08084023
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-27
[patent_title] => 'Maintenance and propagation of mesenchymal stem cells'
[patent_app_type] => utility
[patent_app_number] => 11/625763
[patent_app_country] => US
[patent_app_date] => 2007-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 9341
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/084/08084023.pdf
[firstpage_image] =>[orig_patent_app_number] => 11625763
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/625763 | Maintenance and propagation of mesenchymal stem cells | Jan 21, 2007 | Issued |
Array
(
[id] => 4484489
[patent_doc_number] => 07883698
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-08
[patent_title] => 'Isolation and preservation of fetal hematopoietic and mesencymal system cells from non-controversial materials and/or tissues resulting from miscarriages and methods of therapeutic use'
[patent_app_type] => utility
[patent_app_number] => 11/654737
[patent_app_country] => US
[patent_app_date] => 2007-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7282
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/883/07883698.pdf
[firstpage_image] =>[orig_patent_app_number] => 11654737
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/654737 | Isolation and preservation of fetal hematopoietic and mesencymal system cells from non-controversial materials and/or tissues resulting from miscarriages and methods of therapeutic use | Jan 16, 2007 | Issued |
Array
(
[id] => 4809174
[patent_doc_number] => 20080172752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-17
[patent_title] => 'Neuromedin u receptor subtype 1 deficient transgenic mice and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/654155
[patent_app_country] => US
[patent_app_date] => 2007-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4889
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20080172752.pdf
[firstpage_image] =>[orig_patent_app_number] => 11654155
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/654155 | Neuromedin u receptor subtype 1 deficient transgenic mice and uses thereof | Jan 16, 2007 | Abandoned |
Array
(
[id] => 4809174
[patent_doc_number] => 20080172752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-17
[patent_title] => 'Neuromedin u receptor subtype 1 deficient transgenic mice and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/654155
[patent_app_country] => US
[patent_app_date] => 2007-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4889
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20080172752.pdf
[firstpage_image] =>[orig_patent_app_number] => 11654155
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/654155 | Neuromedin u receptor subtype 1 deficient transgenic mice and uses thereof | Jan 16, 2007 | Abandoned |
Array
(
[id] => 4688220
[patent_doc_number] => 20080032401
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-07
[patent_title] => 'Placental stem cell populations'
[patent_app_type] => utility
[patent_app_number] => 11/648804
[patent_app_country] => US
[patent_app_date] => 2006-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 44264
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20080032401.pdf
[firstpage_image] =>[orig_patent_app_number] => 11648804
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/648804 | Placental stem cell populations | Dec 27, 2006 | Abandoned |
Array
(
[id] => 4951408
[patent_doc_number] => 20080307534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-11
[patent_title] => 'Methods and Compositions for the Detection and Isolation of Ligands'
[patent_app_type] => utility
[patent_app_number] => 12/158383
[patent_app_country] => US
[patent_app_date] => 2006-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12231
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0307/20080307534.pdf
[firstpage_image] =>[orig_patent_app_number] => 12158383
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/158383 | Methods and compositions for the detection and isolation of ligands | Dec 21, 2006 | Issued |